The FDA issued a draft guidance that encourages drugmakers to provide more detailed labeling about whether their products are made from ingredients that contain gluten. This comes from many questions and concerns about oral drugs containing wheat gluten or wheat flour. To read more about the draft guidance and how it will effect labeling, click here.